Clinical Trial Update: Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ticagrelor and clopidogrel in patients with coronary artery disease and type 2 diabetes mellitus; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Spanish Society of Cardiology | Conditions: Coronary Artery Disease, Diabetes Mellitus. Type 2 | Phase 4 | Status: UNKNOWN